Press Releases
Search
-
01 Dec 2021
Business & Solutions
bioMérieux molecular tests efficiently detect SARS-CoV-2 Omicron variant
As the incidence of infections with the SARS-CoV-2 Omicron variant (B.1.1. 529) continues to rise, there is much concern about diagnostic tests ability to efficiently detect this multi-mutated form of...
-
21 Oct 2021
Partnerships
Baxter and bioMérieux announce CE mark for NEPHROCLEAR™ CCL14 test to predict persistent severe acute kidney injury
Baxter International Inc. (NYSE:BAX), a global leader in acute care, and bioMérieux (EPA:BIM), a global leader in in vitro diagnostics, today announced the CE marking of the NEPHROCLEAR™ CCL14 Test. T...
-
21 Oct 2021
bioMérieux – Third-Quarter 2021 Business Review
bioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the nine months ended September 30, 2021.
-
13 Sep 2021
A survey in 5 European countries about sepsis demonstrates the lack of awareness and an expectation for faster diagnostic capabilities
On World Sepsis Day, bioMérieux, a world leader in the field of in vitro diagnostics, and the UK Sepsis Trust, an internationally renowned charity committed to help put an end to preventable deaths fr...
-
01 Sep 2021
bioMérieux – First-Half 2021 Results
The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on August 31 under the chairmanship of Alexandre Mérieux and approved the consolidated financial statemen...
-
24 Jun 2021
bioMérieux launches EPISEQ® SARS-COV-2, a cloud-based software application for the epidemiological surveillance of SARS-CoV-2 variants
bioMérieux, a world leader in the field of in vitro diagnostics, has launched EPISEQ® SARS-COV-2, a genomic software solution to support microbiology labs in identification and reporting from raw sequ...
-
24 Jun 2021
In the fight against Antimicrobial Resistance, bioMérieux and Specific Diagnostics announce a co-exclusive distribution agreement for the SPECIFIC REVEAL® Rapid AST system in Europe
Marcy l’Étoile, France and Mountain View, California – bioMérieux, a world leader in the field of in vitro diagnostics, and Specific Diagnostics, a company bringing unique in vitro diagnostic systems ...
-
07 May 2021
bioMérieux announces the CE marking of the new generation semi-quantitative VIDAS® SARS-COV-2 IgG II serology test.
bioMérieux, a world leader in the field of in vitro diagnostics, today announces CE marking of the new generation of IgG serology test with VIDAS® SARS-COV-2 IgG II to semi-quantitatively detect antib...
-
30 Apr 2021
bioMérieux announces CE-marking of the new MALDI-TOF mass spectrometry identification system: VITEK® MS PRIME
bioMérieux, a world leader in the field of in vitro diagnostics, has announced the CE-marking of VITEK® MS PRIME, the next generation of the VITEK® MS MALDI-TOF mass spectrometry system for routine mi...
-
27 Apr 2021
bioMérieux – First-Quarter 2021 Business Review
bioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the three months ended March 31, 2021.
-
21 Apr 2021
bioMérieux - First Quarter 2011 Business Review
Marcy L'Etoile, France - April 21, 2011. Sales growth: 3.5% like-for-like Strong momentum in North America Temporary slowdown in China and India Robust growth in clinical microbiology 2011 sales growt...
-
07 Apr 2021
bioMérieux announces the CE marking of 3 dengue immunoassays on VIDAS®
bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE marking of its innovative and fully-automated assays to diagnose dengue infection: VIDAS® DENGUE NS1 Ag VIDAS® Anti-DE...
-
24 Mar 2021
bioMérieux announces the CE marking of TB IGRA® test on VIDAS®
Today marks World Tuberculosis (TB) Day and bioMérieux, a world leader in the field of in vitro diagnostics, announces the CE marking of its innovative and fully-automated test VIDAS® TB IGRA (Interfe...
-
18 Mar 2021
BIOFIRE® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 obtains De Novo FDA Authorization
Marcy l’Étoile (France) – bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, its subsidiary specialized in molecular syndromic infectious diseas...
-
09 Mar 2021
The Biotech Digital Campus joins forces with biotechnology schools and training organizations to develop the talents of tomorrow
An unprecedented alliance serving the French bioproduction sector "Recipient of a Future Investment Program award" The Biotech Digital Campus is a recipient of the Engineering Action for innovative pr...